AIDS fungus infections. Fluconazole--a new preparation in development
Keil, T.U.
Fortschritte der Medizin 107(10): 69-70
1989
ISSN/ISBN: 0015-8178 PMID: 2541058 Document Number: 326891
Document emailed within 1 workday
Related Documents
Villagrana-Zesati, Jús.Roberto.; Guerra-Infante, F.M.; Sosa-González, I.Elena. 2013: Clinical efficacy of fluconazole, tinidazole and clindamycin vs fluconazole, tinidazole and azithromycin in the treatment of mixed cervical-vaginal infections, included those caused by Mycoplasma and Chlamydia trachomatis Ginecologia y Obstetricia de Mexico 81(5): 231-238Petrenko, G.T. 1979: Effect of preparation K and its active components on metabolic aspects of the fungus, Microsporum lanosum Mikrobiolohichnyi Zhurnal 41(1): 64-68
Watanakunakorn, C. 1982: Treatment of systemic fungus infections Comprehensive Therapy 8(2): 35-43
Bussaratid, V.; Tansupasawasdikul, S.; Simpson, A.; Pitisuttithum, P.; Phonrat, B.; Howe, P.; White, N.J. 2002: Clinical and mycological responses to fluconazole and fluconazole MIC in oropharyngeal candidiasis in HIV-infected patients Journal of the Medical Association of Thailand 85(7): 757-764
Diz, P.; Ocampo, A.; Miralles, C.; Otero, I.; Iglesias, I.; Martínez, C. 1993: Oro-esophageal candidiasis resistant to fluconazole in patients with AIDS Enfermedades Infecciosas y Microbiologia Clinica 11(1): 36-39
Hu, H-qiang.; Cai, S-yu.; Chen, P. 2007: Recurrent fungus infections tricuspid endocarditis: a case report Zhonghua Xin Xue Guan Bing Za Zhi 35(1): 77
Bozzette, S.A.; Larsen, R.A.; Chiu, J.; Leal, M.A.; Tilles, J.G.; Richman, D.D.; Leedom, J.M.; McCutchan, J.A. 1991: Fluconazole treatment of persistent Cryptococcus neoformans prostatic infection in AIDS Annals of Internal Medicine 115(4): 285-286
Campbell, D.Dee.; Moran, B. 2010: Sustaining the vision for Millennium Development Goal 6, to halt and reverse the spread of HIV/AIDS and other infections Journal of Obstetric Gynecologic and Neonatal Nursing: Jognn 39(5): 600-605
Okudaira, M. 1972: Pathology of deep-seated fungus infections, with special reference to candidiasis, aspergillosis and mucormycosis Rinsho Byori. Japanese Journal of Clinical Pathology 20(5): 330-334
Chin, T.; Fong, I.W.; Vandenbroucke, A. 1990: Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis PharmacoTherapy 10(4): 305-307
Jaruratanasirikul, S. 1996: Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS Southeast Asian Journal of Tropical Medicine and Public Health 27(4): 719-723
Mootsikapun, P.; Chetchotisakd, P.; Anunnatsiri, S.; Choksawadphinyo, K. 2003: The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients Journal of the Medical Association of Thailand 86(4): 293-298
Ablordeppey, S.Y.; Fan, P.; Ablordeppey, J.H.; Mardenborough, L. 1999: Systemic antifungal agents against AIDS-related opportunistic infections: current status and emerging drugs in development Current Medicinal Chemistry 6(12): 1151-1195
Lombardi, G.; Gramegna, G.; Cavanna, C.; Michelone, G. 1990: Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients Microbiologica 13(3): 201-206
De Wit, S.; O'Doherty, E.; De Vroey, C.; Clumeck, N. 1998: Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis Journal of International Medical Research 26(3): 159-170
Piemonte, P.; Conte, G.; Flores, C.; Barahona, O.; Araos, D.; Alfaro, J.; Fardella, P.; Thompson, L. 1996: Emergency of fluconazole-resistant infections by Candida krusei and Candida glabrata in neutropenic patients Revista Medica de Chile 124(9): 1149
Chiu ShiauYen; Chang PoYa; Liao MingHuei; Lu JennYenn; Chang HsiHsung; Wu YingLing 1998: Studies of AIDS in almost aids-excluded Islands: (v) confirmatory combining therapeutic measurements for aids patients and increasing HIV-1 infections in the republic of China Asia Seasonly Report of Environmental Microbiology 6(4): 103-111
Chiu ShiauYen; Chang PoYa; Liao MingHuei; Lu JennYenn; Chang HsiHsung; Wu YingLing 1998: Studies of AIDS in almost aids-excluded Islands: (v) confirmatory combining therapeutic measurements for aids patients and increasing HIV-1 infections in the republic of China Asia Seasonly Report of Environmental Microbiology 6(4): 103-111
Kitamura, K.; Miyagawa, K.; Urabe, A.; Sato, H.; Obayashi, Y.; Aoki, I.; Takaku, F.; Togawa, A.; Shindou, E.; Wakabayashi, Y.; Ohshima, T.; Horikoshi, A.; Nomura, T.; Ohki, I.; Suzuki, K.; Kamakura, M.; Oguchi, A.; Toyama, K.; Yaguchi, M.; Aoki, N.; Kato, A.; Mizoguchi, H.; Masuda, M.; Irie, S.; Fujioka, S. 1996: Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders Japanese Journal of Antibiotics 49(12): 1062-1072
Singh, B.; Cutler, J.C.; Utidjian, H.M. 1972: Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae British Journal of Venereal Diseases 48(1): 57-64